Scott Braunstein, Marinus CEO
After struggling with its sole drug for years, Marinus rides positive data to a commercialization deal in Europe
After a series of painful setbacks, Marinus had a rebirth of sorts last year when it offered a positive late-stage preview of its sole …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
